Global Expansion Apyx is expanding internationally, with Renuvion launching in China and AYON debuting in 2026, signaling solid international demand. Target opportunities include Asia-Pacific clinics, distributors, and regulatory partnerships to grow sales and after-sales support.

Integrated Platform AYON is positioned as a next-generation body contouring platform that merges key technologies, creating upsell opportunities to existing Renuvion/J-Plasma customers and enabling bundled sales to surgeons seeking an all-in-one solution.

Cosmetic Market Momentum Strong marketing and consumer visibility via fashion-week showcases and NewBeauty recognition underscore market interest in minimally invasive aesthetics, providing traction for clinic-level adoption and cross-sell of energy-based devices.

Strong Growth Recent quarterly revenue growth of 32.4% year-over-year and a revenue base in the mid-range suggest expanding demand for energy-based cosmetic and surgical devices, with upsell potential for consumables, service, and training.

Education and Services To accelerate adoption in a competitive field, invest in clinician training, certification programs, regional service centers, and distributor partnerships to support installation, maintenance, and clinical outcomes.